Filing Details
- Accession Number:
- 0001567619-21-008430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-21 20:01:34
- Reporting Period:
- 2021-04-19
- Accepted Time:
- 2021-04-21 20:01:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1644888 | Tao Fu | C/O Zai Lab Limited 4560 Jinke Road, Bldg 1, 4Th Floor Pudong, Shanghai F4 201210 | President & Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-04-19 | 10,000 | $18.92 | 217,000 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-04-19 | 5,800 | $162.55 | 211,200 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-04-19 | 4,000 | $163.38 | 207,200 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-04-19 | 200 | $164.15 | 207,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2021-04-19 | 10,000 | $0.00 | 10,000 | $18.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 470,000 | 2028-09-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 107,500 | Indirect | See footnote |
Footnotes
- The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires September 15, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Reflects a weighted average sale price of $162.55 per share, at prices ranging from $162.02 to $163.00 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $163.38 per share, at prices ranging from $163.05 to $163.78 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $164.15 per share, at prices ranging from $164.14 to $164.15 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Shares held by Reporting Person's spouse.
- The Stock Options vest in equal annual installments over five years beginning on 09/24/2019, the first anniversary of the date of grant.
Billionaire Hedge Funds
